Dalian BIO-CHEM Company Limited / Fundamentals
Income statement
- Net revenue
€175.42M - Cost of goods sold
€108.42M - Gross profit
€67.00M - SG&A expenses
€3.15M - R&D expenses
€7.63M - EBITDA
€42.63M - D&A
€0.00 - EBIT
€40.48M - Interest expenses
€1.90M - EBT
€40.73M - Tax expenses
€5.18M - Net income
€32.42M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€9.88M - Changes in working capital
€0.00 - Operating cash flow
€20.55M - Capex
€9.11M - Other investing cash flow
-€19.92M - Net investing cash flow
-€15.16M - Total cash dividends paid
-€38.13M - Issuance of common stock
€0.00 - Debt repayment
€53.59M - Other financing cash flow
-€2.98M - Net financing cash flow
€12.49M - Foreign exchange effects
€472.03K - Net change in cash
€9.68M - Cash at end of period
€63.77M - Free cash flow
€29.66M
Balance sheet
- Cash and cash equivalents
€64.37M - Cash and short-term investments
€70.32M - Total receivables
€54.64M - Inventory
€134.41M - Other current assets
€17.59M - Total current assets
€276.96M - Property, plant & equipment
€80.88M - Goodwill
€27.43M - Intangible assets
€15.62M - Long-term investments
€0.00 - Other non-current assets
€21.98M - Total non-current assets
€149.02M - Total assets
€425.98M - Accounts payable
€10.25M - Short-term debt
€46.33M - Other current liabilities
€42.84M - Total current liabilities
€102.31M - Long-term debt
€59.43M - Deferred tax liabilities
€4.68M - Other non-current liabilities
€906.18K - Total non-current liabilities
€66.53M - Total liabilities
€168.84M - Common stock
€84.03M - Retained earnings
€70.07M - Other equity
€0.00 - Total equity
€257.13M - Total liabilities and shareholders' equity
€425.98M
Company information
- Market capitalization
€1.89B - Employees
953 - Enterprise Value
€14.27B
Company ratios
- Gross margin
-
38.2% Even with peer group: 36.3% - EBITDA margin
-
24.3% Better than peer group: 18.7% - EBIT margin
-
23.1% Better than peer group: 11.8% - EBT margin
-
23.2% Better than peer group: 12.7% - Net margin
-
18.5% Better than peer group: 10.0% - ROE
-
12.6% Even with peer group: 9.9% - ROA
-
7.6% Even with peer group: 6.6% - Asset turnover
-
41.2% Worse than peer group: 60.4% - FCF margin
-
6.5% Better than peer group: -2.0% - FCF yield
0.6% - Efficiency ratio
75.7% - Net sales per employee
-
€184.07K - Net income per employee
-
€34.02K